Alizadeh 2014
|
Used oral medication
|
Amos 1994
|
Used a composite symptom score only
|
Attila 1993
|
Used a mixture of drugs
|
Boyle 1986
|
Used a composite outcome score only
|
Brown 1990
|
Used a composite outcome score only
|
Cauwenbergh 1986
|
Used a composite outcome score only
|
Chappell 2014
|
Used a composite outcome score only
|
Cheng 2001
|
Not a randomised trial (as assessed by native speaker)
|
Cicek 2009
|
Does not involve antifungal drugs
|
Comert 2007
|
Used a composite outcome score only
|
CTRI/2009/091/001079
|
Used a combination of antifungals for treatment
|
Davies 1999
|
Combined antifungal with another drug having a different mode of action
|
Efalith Trial Group 1992
|
Used a mixture of lithium and zinc
|
Emad 2000
|
Abstract with insufficient data; no full text retrieved
|
Emtestam 2012
|
Drugs used in this trial were not antifungal
|
Ermosilla 2005
|
Outcome variable used is a composite of symptom scores; this falls within our exclusion criteria
|
Ernst 1990
|
Non-randomised study
|
Ford 1984
|
Evaluated orally administered ketoconazole
|
Gayko 2006
|
Ketoconazole was compared with a combination of ketoconazole and another drug
|
Goldust 2013(a)
|
No outcomes reported
|
Gupta 2006
|
This was a qualitative review
|
Humke 2002
|
Conference abstract; not able to retrieve full text
|
Iraji 2005
|
Abstract; did not provide enough data; not able to retrieve full text
|
Iudica 2001
|
This was a commentary on another article (Parsad 2001a)
|
Jensen 2009
|
Abstract with insufficient data; not able to retrieve full text
|
Kaszuba 2005
|
Study evaluated orally administered Itraconazole
|
Koca 2003
|
Used a composite outcome score only
|
Kozlowska 2007
|
Used a composite outcome score only
|
Li 1996
|
Not a randomised trial as assessed by native speaker
|
Loden 2000
|
Combined antifungal with a drug having a different mode of action
|
Lorette 2006
|
Combined 2 antifungals versus a third antifungal (or placebo) (ciclopiroxolamine/zinc pyrithione)
|
Meyer-Rohn 1979
|
This study deals with patients with non-seborrhoeic dermatitis
|
NCT00703846
|
Open-label phase 4 trial without control group
|
NCT01139749
|
Used oral medication
|
Ozcan 2007
|
Metronidazole is not an antifungal
|
Parsad 2001
|
Metronidazole is not an antifungal
|
Pedrinazzi 2009
|
Used peat; we excluded herbal treatments
|
Peter 1995
|
Used a composite outcome score only
|
Pierard-Franchimont 2002b
|
Used a composite outcome score only
|
Pierard-Franchimont 2002c
|
Outcome variables in this study were sebum excretion rate and percentage of anagen hair, which did not fulfil our inclusion criteria
|
Prensner 2003
|
This is a commentary on a study that was previously conducted
|
Quadri 2005
|
Authors (Milani) were contacted; data not available anymore
|
Rigoni 1989
|
Non-randomised study
|
Salmanpoor 2012
|
This was a Letter to the Editor
|
Scaparro 2001
|
Used oral medication
|
Schmidt-Rose 2011
|
Used a composite outcome score only
|
Schwartz 2013
|
Combined antifungal with a drug having a different mode of action (zinc pyrithione and climbazole)
|
Seite 2009
|
Combined antifungal with a drug having a different mode of action
|
Siadat 2006
|
Metronidazole is not an antifungal
|
Sparavigna 2013
|
Combined 2 antifungals vs placebo
|
Squire 2002
|
Combined antifungal with a drug having a different mode of action
|
Syed 2008
|
Herbal extract
|
Trznadel-Grodzka 2012
|
This study was not a clinical trial
|
Vena 2005
|
Used a composite outcome score only
|
Xu 1996
|
Not a randomised trial (as assessed by native speaker)
|